Form 4: Myomo Director William Febbo Receives RSU Grant

Director William J. Febbo was granted 45,000 restricted stock units in Myomo, Inc. vesting on the first anniversary of the grant.

Summary

• Director William J. Febbo acquired 45,000 restricted stock units (RSUs) of Myomo, Inc. common stock.
• The transaction occurred on April 14, 2026.
• The RSUs were granted under the Issuer's 2018 Stock Option and Incentive Plan.
• The units vest in their entirety on the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon vesting.

Risks

• Market volatility affecting the value of equity compensation.

Future Outlook

The RSUs are scheduled to vest in their entirety on April 14, 2027.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term performance and align leadership with shareholder outcomes in the medical technology sector.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices for small-cap medical device companies.
• Vesting schedules of one year for director equity are common in the industry to ensure retention and commitment.

Stakeholder Impact

• Shareholders may experience minor dilution upon the vesting of these units.

Next Steps

• Vesting of the 45,000 RSUs on April 14, 2027.

Key Dates

Keywords

Myomo, MYO, Form 4, Insider Trading, Restricted Stock Units, Equity Compensation